Clinical Trial Update: Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update exploring multidisciplinary design to optimize schizophrenia treatment using multi-omics data and systems biology analyses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis
• Schizophrenia
• Treatment-resistant Schizophrenia

Snippet

Sponsor: Consorcio Centro de Investigación Biomédica en Red (CIBER) | Conditions: Schizophrenia, Treatment-resistant Schizophrenia | Phase 4 | Status: UNKNOWN